The Global Immunoglobulin Market reached approximately US$16.24 billion in 2023 and is expected to grow to US$35.85 billion by 2032, representing a CAGR of 9.3% during the forecast period 2024-2032.   This growth comes from the increasing number of autoimmune and immunodeficiency disorders, improvements in immunoglobulin therapies, including subcutaneous and intravenous options, and...